Ananda Pharma, now the leading force in pharmaceutical cannabis research in the UK, has announced that the former Chief Operating
A groundbreaking achievement is flying under the radar. Epidiolex, the first FDA approved cannabis-derived drug developed by GW Pharmaceuticals, is on track to surpass $1 billion in annual revenue—a feat that puts it in the league of blockbuster drugs like Humira and Lipitor.
British American Tobacco Tobacco giant British American Tobacco (BAT) has announced the launch of a second investment fund as
UK-based biotech firm Ananda Developments has solidified its position as a driving force in clinical cannabis research in Europe, announcing the launch of two more major trials using its proprietary compounds.
As reported by Cannabis Health Avata Biosciences is developing solid dose cannabinoid medicines for epilepsy and other neurological disorders, with
Germany’s passage of CanG continues to drive up stock prices Yesterday, the President of Bundesrat, Manuela Schwesig, signed Germany’s landmark
Big pharma has so far been cautious of diving headfirst into the cannabis industry, despite the growing body of evidence
German Stocks Spike on Passage of Draft Law Synbiotic SE (SBX) Yesterday, the German federal cabinet officially passed the draft
WITH the fast-growing CBD sector tied up in a regulatory quagmire hundreds of transatlantic industry players face an uncertain future. However, one
We won’t spam you
© 2024 Prohibition Holdings Ltd. All Rights Reserved.
